Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
|
|
Dimension Therapeutics, Inc. (DMTX)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 11/17/2017 |
15-12B
| Form 15-12B - Securities registration termination [Section 12(b)]: |
| 11/14/2017 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 11/09/2017 |
4
| FMR LLC (See Remark 1) has filed a Form 4 on Dimension Therapeutics, Inc.|
Txns:
| Unknown transaction of 3,838,249 shares
@ $6, valued at
$23M
Unknown transaction of 1,050,016 shares
@ $6, valued at
$6.3M
Unknown transaction of 5,057 shares
@ $6, valued at
$30.3k
|
|
| 11/07/2017 |
4
| Wadsworth Samuel C. (Chief Scientific Officer) has filed a Form 4 on Dimension Therapeutics, Inc.|
Txns:
| Disposed/sold 278,035 shares
@ $0
Disposed/sold 50,000 options to buy
@ $7.14, valued at
$357k
Disposed/sold 60,000 options to buy
@ $1.9, valued at
$114k
|
|
| 11/07/2017 |
4
| Thistle Mary (COO) has filed a Form 4 on Dimension Therapeutics, Inc.|
Txns:
| Disposed/sold 27,711 options to buy
@ $3.57, valued at
$98.9k
Disposed/sold 180,815 options to buy
@ $3.57, valued at
$645.5k
Disposed/sold 17,104 options to buy
@ $4.09, valued at
$70k
Disposed/sold 65,000 options to buy
@ $7.14, valued at
$464.1k
Disposed/sold 60,000 options to buy
@ $1.9, valued at
$114k
|
|
| 11/07/2017 |
4
| Morris Arlene (Director) has filed a Form 4 on Dimension Therapeutics, Inc.|
Txns:
| Disposed/sold 44,474 options to buy
@ $4.85, valued at
$215.7k
Disposed/sold 32,069 options to buy
@ $7.08, valued at
$227k
Disposed/sold 17,000 options to buy
@ $1.15, valued at
$19.6k
|
|
| 11/07/2017 |
4
| MIGAUSKY GEORGE V (Director) has filed a Form 4 on Dimension Therapeutics, Inc.|
Txns:
| Disposed/sold 55,772 options to buy
@ $4.09, valued at
$228.1k
Disposed/sold 32,069 options to buy
@ $7.08, valued at
$227k
Disposed/sold 17,000 options to buy
@ $1.15, valued at
$19.6k
|
|
| 11/07/2017 |
4
| Jenkins Annalisa (President and CEO) has filed a Form 4 on Dimension Therapeutics, Inc.|
Txns:
| Disposed/sold 481,696 options to buy
@ $0.56, valued at
$269.7k
Disposed/sold 74,375 options to buy
@ $3.57, valued at
$265.5k
Disposed/sold 342,113 options to buy
@ $4.09, valued at
$1.4M
Disposed/sold 160,000 options to buy
@ $7.14, valued at
$1.1M
Disposed/sold 192,000 options to buy
@ $1.9, valued at
$364.8k
Disposed/sold 150,000 options to buy
@ $1.35, valued at
$202.5k
|
|
| 11/07/2017 |
4
| Hohneker John (Director) has filed a Form 4 on Dimension Therapeutics, Inc.|
Txns:
| Disposed/sold 38,000 options to buy
@ $4.6, valued at
$174.8k
|
|
| 11/07/2017 |
4
| GEMAYEL GEORGES (Director) has filed a Form 4 on Dimension Therapeutics, Inc.|
Txns:
| Disposed/sold 44,474 options to buy
@ $4.85, valued at
$215.7k
Disposed/sold 32,069 options to buy
@ $7.08, valued at
$227k
Disposed/sold 17,000 options to buy
@ $1.15, valued at
$19.6k
|
|
| 11/07/2017 |
4
| Dybbs Michael (Director) has filed a Form 4 on Dimension Therapeutics, Inc.|
Txns:
| Disposed/sold 32,069 options to buy
@ $7.08, valued at
$227k
Disposed/sold 17,000 options to buy
@ $1.15, valued at
$19.6k
|
|
| 11/07/2017 |
4
| Crombez Eric (Chief Medical Officer) has filed a Form 4 on Dimension Therapeutics, Inc.|
Txns:
| Disposed/sold 128,292 options to buy
@ $0.56, valued at
$71.8k
Disposed/sold 80,396 options to buy
@ $4.09, valued at
$328.8k
Disposed/sold 50,000 options to buy
@ $7.14, valued at
$357k
Disposed/sold 50,000 options to buy
@ $1.9, valued at
$95k
|
|
| 11/07/2017 |
4
| Colowick Alan (Director) has filed a Form 4 on Dimension Therapeutics, Inc.|
Txns:
| Disposed/sold 44,474 options to buy
@ $4.85, valued at
$215.7k
Disposed/sold 17,000 options to buy
@ $1.15, valued at
$19.6k
Disposed/sold 32,069 options to buy
@ $7.08, valued at
$227k
|
|
| 11/07/2017 |
8-K
| Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Sta... |
| 11/07/2017 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
| 11/07/2017 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 11/07/2017 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 11/07/2017 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 11/07/2017 |
25-NSE
| Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities: |
| 11/07/2017 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 11/07/2017 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
| 11/06/2017 |
10-Q
| Quarterly Report for the period ended September 30, 2017 |
| 10/26/2017 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
| 10/23/2017 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
| 10/17/2017 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
| 10/12/2017 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
| 10/11/2017 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
| 10/10/2017 |
SC 14D9
| Form SC 14D9 - Solicitation, recommendation statements: |
| 10/10/2017 |
SC TO-T
| Form SC TO-T - Tender offer statement by Third Party: |
| 10/03/2017 |
425
| Form 425 - Prospectuses and communications, business combinations: |
| 10/03/2017 |
SC14D9C
| Form SC14D9C - Written communication relating to third party tender offer: |
| 10/03/2017 |
SC TO-C
| Form SC TO-C - Written communication relating to an issuer or third party: |
| 10/03/2017 |
SC14D9C
| Form SC14D9C - Written communication relating to third party tender offer: |
| 10/03/2017 |
8-K
| Quarterly results |
|
|
|